Satellos Bioscience MSLE
NASDAQ MSLE
$10.01 -0.18 (-1.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Property, Plant & Equipment (Net) (2023 - 2026)

Satellos Bioscience (MSLE) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Satellos Bioscience 206.75 Mn 206.75 Mn - 7,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 8,000.00
Mar 31, 2026 8,000.00
Dec 31, 2025 5,000.00
Dec 31, 2025 5,000.00
Dec 31, 2024 3,579.25
Dec 31, 2024 3,579.25
Dec 31, 2023 13,956.18
Dec 31, 2023 13,956.18